Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.

This publication has 17 references indexed in Scilit:

• Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism
  The Journal of Pharmacology and Experimental Therapeutics, 2025
• Active secretion and enterocytic drug metabolism barriers to drug absorption1PII of original article: S0169-409X(96)003304. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 99–112.1
  Advanced Drug Delivery Reviews, 2001
• (+)-Bufuralol 1′-hydroxylation activity in human and rhesus monkey intestine and liver
  Biochemical Pharmacology, 1995
• Contribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits.
  1995
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  1994
• Individual Variation in First-Pass Metabolism
  Clinical Pharmacokinetics, 1993
• Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.
  1990
• Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers
  Clinical Pharmacology & Therapeutics, 1983
• Prediction of intestinal first-pass effect of phenacetin in the rat from enzyme kinetic data — correlation with in in vivo data using mucosal blood flow
  Biochemical Pharmacology, 1982
• PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
  Journal of Biological Chemistry, 1951